Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Acceptability of Paediatric Wrist Orthoses Through Co-design

NCT07861958 · tracked via the Priya Life Science Italy tracker
Phase
Not applicable
Started
2026-06-18
Last updated
2026-10-06

Condition(s) studied

Cerebral Palsy (CP)Brain InjuriesNeuromotor Dysfunction

Investigational drug(s) / intervention(s)

Orthosis acceptability

Orthosis acceptability: Participants will receive a personalized wrist-hand orthosis developed through a co-design process. During two structured workshops, children and caregivers express aesthetic preferences and personalization needs using creative tools (drawings, collage, 3D-printed prototypes). Upper limb anatomy is acquired via 3D scanning and/or anthropometric measurements. The orthosis is then digitally designed, 3D-printed with biocompatible materials using a multicolor FDM printer, finished manually, and certified as a custom medical device per MDR 745/2017. Participants evaluate the co-designed orthosis in terms of acceptability (TAM-3), satisfaction (QUEST 2.1), and upper limb functional performance (optoelectronic motion analysis), comparing outcomes with their conventional orthosis assessed at baseline.

Study summary

The goal of this pilot interventional study (pre-post design) is to learn if a co-designed wrist-hand orthosis can improve acceptability compared to a conventional orthosis in children aged 6 to 14 years with neuromotor disorders following acquired or congenital brain injury.

The main questions it aims to answer are:

Does a wrist-hand orthosis developed through a co-design process with the pediatric patient show greater acceptability - measured via the Technological Acceptance Measure (TAM-3) - compared to the conventional orthosis already used by the patient? Does the co-designed orthosis guarantee at least equivalent functional performance to the conventional orthosis, as assessed through upper limb kinematic analysis?

Researchers will compare the co-designed orthosis to the conventional orthosis to see if the co-design and personalization process improves acceptance, satisfaction, and functional outcomes.

Participants will:

Complete acceptance and satisfaction questionnaires (TAM-3 and QUEST 2.1) and undergo functional upper limb assessment while wearing their conventional orthosis Participate in two structured co-design workshops (\~1.5 hours each) involving creative and expressive activities to define preferences for their personalized orthosis Receive and wear the co-designed 3D-printed orthosis, then repeat functional assessments and questionnaires, and take part in a semi-structured interview about their co-design experience.

Eligibility

Sex
ALL
Min age
6 Years
Max age
14 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 6 and 14 years * Current user of a wrist-hand orthosis for rehabilitative and/or assistive purposes * Diagnosis of neuromotor disorder following acquired or congenital brain injury (e.g., cerebral palsy) * Adequate verbal and communicative abilities to participate in interviews and co-design activities * Currently followed at IRCCS Eugenio Medea, Bosisio Parini (LC) * Written informed consent provided by parent or legal guardian Exclusion Criteria: * Age below 6 years or above 14 years * Absence of adequate verbal and communicative abilities to participate in interviews and co-design activities (e.g., non-functional or severely limited language) * Skin allergies * Behavioural or psychiatric disorders (e.g., emotional problems, anxiety, panic attacks)

Primary outcome measure(s)

  • Change in wrist-hand orthosis acceptability as measured by the Technological Acceptance Measure (TAM-3) score between first and last study visit — Baseline and up to 12 months
    Orthosis acceptability is measured using the TAM-3, adapted for the pediatric population, evaluating 9 constructs across 27 items: perceived usefulness, perceived ease of use, self-efficacy, perception of external control, playfulness, anxiety, enjoyment, output quality, and behavioural intention. Each construct is scored as the mean of its items on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree); higher scores indicate greater acceptability, except for the anxiety subscale where lower scores indicate better outcome. The questionnaire is administered separately to the child and caregiver at baseline (conventional orthosis) and at the final visit (co-designed orthosis). Change from baseline is calculated as the difference between final and baseline scores for each subscale.

Trial sites (1)

FacilityCityRegionStatus
Scientific Institute IRCCS E.Medea Bosisio Parini Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07861958 on ClinicalTrials.gov ↗ ← All trials in Italy